Journal of Child and Adolescent Psychopharmacology
Journal metrics
Annual Clarivate and SCImago indicators.
| Year | JCR | SJR | ||||
|---|---|---|---|---|---|---|
| IF | IF quartile | Rank (percentile) | SJR | SJR quartile | Rank (percentile) | |
| 2025 | 1.8 | Q2 | 53.6% | 0.618 | Q2 | 68.7% |
| 2024 | 2.2 | Q2 | 70.7% | 0.619 | Q2 | 69.4% |
| 2023 | 1.5 | Q3 | 36.4% | 0.604 | Q2 | 71.1% |
| 2022 | 1.9 | Q3 | 35.2% | 0.774 | Q1 | 79.6% |
| 2021 | 3.0 | Q3 | 55.3% | 1.033 | Q1 | 87.2% |
| 2020 | — | — | 0.935 | Q1 | 83.8% | |
| 2019 | — | — | 0.996 | Q1 | 85.5% | |
| 2018 | — | — | 1.000 | Q1 | 84.2% | |
Impact history
Annual SJR and Impact Factor trend.
SJRIF
Journal record
eISSN
1557-8992
ISSN
1044-5463
country
UScoverage
1990-2026